600285.SS
600285.SS
CNE000001501
HENAN LINGRUI PHARMACEUTICAL
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 3.853.391.130 3.500.831.287
10.1%
Cost of Revenue 769.552.147 846.562.046
9.1%
Gross Profit 3.083.838.983 2.654.269.240
16.2%
2.245.380.704 1.896.847.703
18.4%
Operating Income 838.458.278 757.421.538
10.7%
Pretax Income 879.465.631 827.572.997
6.3%
Net Income Common Stockholders 759.503.033 722.550.720
5.1%
-- --
--
-- --
--
ende